Meet, discuss & support other patients or families living with Waldenstrom macroglobulinemia. Participate in group discussions. Contribute to topics, or just share what's on your mind

Waldenstrom macroglobulinemia community news

  • -

    New WM Clinic in the UK
    News, published 3 months ago

    show transcript


    Conditions treated

    Waldenström’s macroglobulinaemia, paraprotein-associated neuropathies

    Service performance

    Waldenström’s macroglobulinaemia: approx. 60 patients are registered in the service, either on treatment or follow-up.
    Neuropathy/MGUS patients: approx. 40 patients registered and under review. Patients are seen within two to four weeks of receipt of referral, depending on the clinical urgency of the case.
     

  • -

    One on One: Peter DeNardis Pitt staffer’s efforts recognized with Jefferson Award
    News, published 7 months ago

    show transcript


    And DeNardis really knows of what he speaks: In 2003 at age 43, with a wife of 20 years and kids aged 16, 14 and 7, he was diagnosed with WM and told that the disease likely would kill him in a few years.

  • -

    WM Clinical Trials
    News, published 8 months ago

    show transcript


    via Clinicaltrials.gov

  • -

    Bing Center for WM
    News, published 8 months ago

    show transcript


    The Waldenstrom’s Macroglobulinemia program at Dana Farber Cancer Institute (DFCI) was founded in 1999 by Dr. Steve Treon with the help of patients,caregivers and DFCI scientists in an effort to advance our understanding of the cause of WM, and to pursue novel therapies. 

  • -

    European Medicines Agency
    News, published 8 months ago

    show transcript


    The European Medicines Agency is a decentralised agency of the European Union, located in London. The Agency is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union.

  • -

    European Society for Medical Oncology
    News, published 8 months ago

    show transcript


    The European Society for Medical Oncology (ESMO), the leading European professional organization representing medical oncologists.

  • -

    Rare Cancers Europe
    News, published 8 months ago

    show transcript


    Rare Cancers Europe (RCE) has been established as a partnership of cooperating organisations that work together to place the issue of rare cancers firmly on the European policy agenda, to identify and promote appropriate solutions and to exchange best practice.

  • -

    Lymphoma Coalition
    News, published 8 months ago

    show transcript


    We are a global network of worldwide not for profit lymphoma patient organisations with a Vision to free the world of lymphomas. We began in 2002 with 4 countries sharing best practices and now have a membership of 53 member organisations from 38 countries.

  • -

    IWMF
    News, published 8 months ago

    show transcript


    The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) was established in 1994 for the purpose of offering educational information and caring support to Waldenstrom’s macroglobulinemia (WM) patients. Since the year 2000 we have funded research that will lead to better treatment therapies and, we hope, eventually a cure.

  • -

    Waldenström's Macroglobulinemia Clinical Trials Group
    News, published 8 months ago

    show transcript


    The Waldenström's Macroglobulinemia Clinical Trials Group is comprised of over 20 major cancer centers around the world.